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PP-146 Establishment of highly efﬁcient full-length
HCV 1b genome cell culture system by inserting
long distant structural fragment into replicon
Y.L. Zeng1 *, Y.P. Zhou1, J.T. Li1, J.F. Wei1, H.H. Huang1,
J.J. Wang1, S.W. Liu2, Y.S. Wu2. 1Nanfang Hospital,
Southern Medical University, 2Southern Medical University,
China
Objectives: To establish a full-length genome of hepatitis C
virus (HCV) 1b, the dominant strain in China, cell culture
system for further study.
Methods: The 5′-end of half HCV-1b genome (5.2kb) was
ampliﬁed from Chinese chronic hepatitis C patients’ seral
samples with the reﬁned long distant RT-PCR technique. The
full length recombinant plasmid of HCV 1b was constructed
by inserting the long distant structural regions directly into
HCV 1b replicon containing the non-structural regions. In
vitro transcribed genomic HCVRNA was transfected into
Huh7.5.1 cells by liposome-mediated method. The real
time quantitative RT-PCR, Western Blot, inoculation of
naı¨ve Huh7.5.1 cells, immune ﬂuorescence and titration
of infectious HCV were used for identiﬁcation of HCV
replication and presence of infectious virion.
Results: The real time quantitative RT-PCR assay revealed
the highest titer of HCV was 6.5×107 copies/mL in the
cultural supernatants. While both Western Blot analysis and
immune ﬂuorescence conﬁrmed the expression of HCV core
protein in the transfected cells. Subsequent infection of
naı¨ve Huh7.5.1 cells with supernatant of HCV cell culture
resulted in high levels of HCV proteins and RNAs.
Conclusions: These results demonstrate the successful
establishment of a HCV 1b culture system by the new
strategy of inserting long distant structural amplicon into
replicon that produces infectious virus, which will allow the
study of each aspect of the entire HCV life cycle and related
studies.
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Background: HCV infection became a worldwide threat
to human health, which can led to chronic hepatitis C,
cirrhosis and hepatoma. As only human and chimpanzees are
susceptible to hepatitis C virus, the progress of HCV research
has been obstructed due to the absence of a reliable small
primate animal model. GB virus B (GBV-B), being very close
to hepatitis C virus (HCV) phylogenetically, can replicate
effectively in vivio of common marmosets, that has been
made an attractive surrogate virus for HCV replication study.
It was reported that HCV NS2-NS3 protease, NS3 protease
and NS4A complex are critical for virus maturation and
replication. The construction of chimeric GB Virus B with
Hepatitis C NS2-NS4A region can be used to develop a
marmoset model for antiviral and immune studies.
Methods: RT-PCR and overlapping PCR were applied to
complete jointing gene fragments and T7 transcription kit
was used to produce chimeric GBV-B/HCV infectious RNA
in vitro.
Results: A chimeric clone originating from GB virus B
(GBV-B), in which GBV-B NS2-NS4A region are replaced by
analogous sequence of the HCV genome, was constructed.
Conclusions: This chimeric clone lays the roots for a
surrogate model of Hepatitis C virus, insights into HCV
replication mechanism and further HCV NS3 epitope-based
research.
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Background: Hepatitis C virus (HCV) infection is a major
public health problem in China. However systematic studies
conducted on mechanism of recovery and chronic infection
with HCV are little known. A detailed study was carried
out to investigate IFN-a and IFN-g correlating to antibody
reactivity and viral factors in the population of recovered
and chronic HCV infection from blood donors.
Methods: 160 plasmas samples reactive with anti-HCV
assays were collected from blood donors in Guangdong and
Beijing. HCV antibody reactivity was presented as S/CO by
at least three EIA assays. All samples were tested for ALT
and viral load, conﬁrmed by nested-PCR, and classiﬁed as
three statuses of recovery (RNA /Ab+), chronic (RNA+/Ab+)
and false positive (RNA /Ab ) infections. Productions of
IFN-a and IFN-g in the serum were also quantiﬁed
by ELISA. The genotypes of HCV from chronic samples
were phylogenetically analyzed with 5′-NCR sequences
(215 218bp).
Results: 45 recovery, 76 chronic and 39 false positive of 160
HCV antibody positive plasmas were ﬁnally conﬁrmed. The
rate of recovered HCV infected individuals in blood donors
was 37.2% proximately. 63 HCV strains were genotyped,
